Angelika Lueking

Title: Angelika Lueking: Innovator in Diagnostic Methods

Introduction

Angelika Lueking is a prominent inventor based in Bochum, Germany. She has made significant contributions to the field of diagnostics, particularly in the identification and characterization of high-affinity binders. Her innovative work has the potential to enhance diagnostic methods in various medical applications.

Latest Patents

Angelika Lueking holds a patent for a "Method for diagnosis of high-affinity binders and marker sequences." This invention relates to a novel method for diagnosing high-affinity binders, specifically antibodies or autoantibodies. It also involves the identification, characterization, and selection of marker sequences for diagnostic use, particularly in the form of a panel. The invention includes a singleplex assay that utilizes the discovered selection of marker sequences to detect high-affinity binders using a single signal. This patent showcases her expertise and commitment to advancing medical diagnostics.

Career Highlights

Angelika Lueking is associated with Protagen AG, where she continues to work on innovative solutions in the field of diagnostics. Her role at the company allows her to collaborate with other experts and contribute to groundbreaking research and development.

Collaborations

Some of her notable coworkers include Stefan Müllner and Peter Schulz-Knappe. Their collaboration fosters a dynamic environment for innovation and the advancement of diagnostic technologies.

Conclusion

Angelika Lueking's contributions to the field of diagnostics through her innovative patent demonstrate her dedication to improving medical practices. Her work has the potential to significantly impact the way high-affinity binders are diagnosed and utilized in clinical settings.